• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Thursday, January 28, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

A subtle change in the DNA may predispose to polyneuropathy after gut infection

Bioengineer by Bioengineer
January 7, 2021
in Chemistry
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Department of Immunology, TMDU

Tokyo, Japan – Guillain-Barré syndrome is an infamous autoimmune neuropathy, yet genetic variants predisposing individuals to this disease have yet to be described. In a new study, researchers from Tokyo Medical and Dental University (TMDU) discovered two novel genetic variants in a protein made by antibody-forming immune cells, providing a mechanism for the development of the disease.

The body’s immune system is supposed to fight off invaders; however, in autoimmune diseases this defense goes rogue and attacks the host instead through the production of autoantibodies. Guillain-Barré syndrome (GBS) is an acutely developing, autoimmune peripheral neuropathy that leads to muscle weakness and numbness. It is based on the production of autoantibodies against gangliosides, a specific type of lipid molecules on the membranes of cells of the nervous system, which in turn damage those neurons and result in polyneuropathy. That is, damage to multiple peripheral nerves that may cause muscle weakness and numbness. GBS is often preceded by an immune stimulation such as an infection. Indeed, infection with the bacterium Campylobacter jejuni, causing a diarrheal illness, is the most common event before GBS develops. However, as not all patients with this bacterial illness then develop GBS, it has long been thought that genetic variants (small differences in the DNA between individuals) may be what predisposes patients with GBS to the polyneuropathy.

“GBS remains somewhat of a medical mystery. We do not fully understand why patients develop this disease,” says corresponding author of the study Professor Takeshi Tsubata. “The goal of our study was to identify genetic variants in patients with GBS and provide a potential mechanism for the production of autoantibodies that lead to the development of polyneuropathy in these patients.”

To achieve their goal, the researchers focused on the protein Siglec-10. Siglec-10 is produced by B lymphocytes, a specific type of immune cell that produces antibodies, and binds to gangliosides. The researchers hypothesized that Siglec-10 may play an inhibitory role in the production of antibodies against gangliosides, and in turn that genetic variants in Siglec-10 may diminish this inhibitory role and thus facilitate the development of GBS. By analyzing the DNA sequence encoding for the protein Siglec-10 in patients with GBS, the researchers identified two rare variants that change the amino acid sequence in the protein in GBS patients. There were no patients with only one of the two variants probably because these two variants are located very closely in the Siglec-10 gene.

The researchers then made the GBS-specific Siglec-10 protein in the lab to understand how it differs from the normal Siglec-10 protein at the molecular level. They found that only one of the two variants was responsible for the deleterious effects of the alternate protein, causing a marked alteration in the molecular structure of the protein and in turn a significant impairment of the protein to bind gangliosides.

“These are striking results that show how Siglec-10 suppresses antibody production of gangliosides, and in turn how a variant protein may predispose to the development of Guillain-Barré syndrome. These findings help us understand the pathophysiology of the disease,” says first author of the study Amin Alborzian Deh Sheikh.

###

The article, “A Guillain-Barré syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides” was published in Journal of Autoimmunity at DOI: 10.1016/j.jaut.2020.102571

Media Contact
Takeshi TSUBATA
[email protected]

Original Source

http://www.tmd.ac.jp/english/press-release/20201125-1/index.html

Related Journal Article

http://dx.doi.org/10.1016/j.jaut.2020.102571

Tags: BiochemistryBiologyGeneticsMolecular Biology
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

Enhanced recovery efforts for cesarean delivery reduce need for opioids by 80%

January 28, 2021
IMAGE

A metalens for virtual and augmented reality

January 27, 2021

Precision measurements of intracluster light suggest possible link to dark matter

January 27, 2021

Scientists jump-start two people’s brains after coma

January 27, 2021
Next Post
IMAGE

Research shows rising lizard temperatures may change predator-prey relationship with snakes

IMAGE

What are the performance limits of our brain?

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    54 shares
    Share 22 Tweet 14
  • People living with HIV face premature heart disease and barriers to care

    69 shares
    Share 28 Tweet 17
  • New drug form may help treat osteoporosis, calcium-related disorders

    41 shares
    Share 16 Tweet 10
  • New findings help explain how COVID-19 overpowers the immune system

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

MaterialsTechnology/Engineering/Computer ScienceGeneticscancerBiologyClimate ChangeInfectious/Emerging DiseasesMedicine/HealthChemistry/Physics/Materials SciencesCell BiologyPublic HealthEcology/Environment

Recent Posts

  • Reconstruction shows increased global warming trends since 1850s
  • From the clinic to the lab, understanding medulloblastoma relies on molecular profiling
  • ETRI develops VR sickness quantification analysis technology
  • Enhanced recovery efforts for cesarean delivery reduce need for opioids by 80%
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In